Company Filing History:
Years Active: 2007
Title: Burkhard Göke: Innovator in Diabetes Treatment
Introduction
Burkhard Göke is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of diabetes treatment through his innovative research and patenting efforts. His work focuses on improving the response of pancreatic beta-cells in individuals with impaired glucose tolerance.
Latest Patents
Göke holds a patent for a composition aimed at treating impaired glucose tolerance (IGT). The patent, titled "Exendin improves β-cell response in subjects with impaired glucose tolerance," describes a composition that includes a compound binding to a receptor for glucagon-like peptide-1, along with a pharmaceutical carrier. This composition is designed to enhance pancreatic β-cell sensitivity to blood glucose levels in humans suffering from IGT. Additionally, the patent outlines a method for improving insulin secretory responses in these individuals through the administration of the described composition.
Career Highlights
Burkhard Göke is associated with Amylin Pharmaceuticals, Inc., where he continues to advance his research in diabetes treatment. His work has been instrumental in developing therapies that address the challenges faced by individuals with glucose metabolism disorders.
Collaborations
Göke has collaborated with notable colleagues, including Maria Byrne and Thomas R. Coolidge. These partnerships have contributed to the success of his research and the development of innovative solutions in the field of diabetes.
Conclusion
Burkhard Göke's contributions to diabetes treatment through his patent and collaborative efforts highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in managing impaired glucose tolerance and improving patient outcomes.